REMAGIN Trademark

Trademark Overview

On Wednesday, October 21, 2020, a trademark application was filed for REMAGIN with the United States Patent and Trademark Office. The USPTO has given the REMAGIN trademark a serial number of 90269960. The federal status of this trademark filing is REGISTERED as of Tuesday, June 21, 2022. This trademark is owned by Remagin, LLC. The REMAGIN trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Ophthalmology and oculofacial plastic surgery
remagin

General Information

Serial Number90269960
Word MarkREMAGIN
Filing DateWednesday, October 21, 2020
Status700 - REGISTERED
Status DateTuesday, June 21, 2022
Registration Number6769036
Registration DateTuesday, June 21, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2021

Trademark Statements

Goods and ServicesOphthalmology and oculofacial plastic surgery

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 10, 2020
Primary Code044
First Use Anywhere DateMonday, March 1, 2021
First Use In Commerce DateMonday, March 1, 2021

Trademark Owner History

Party NameRemagin, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWindermere, FL 34786
Party NameRemagin, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWindermere, FL 34786
Party NameRemagin, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWindermere, FL 34786

Trademark Events

Event DateEvent Description
Tuesday, June 21, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 21, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, May 14, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, May 13, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 18, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, April 4, 2022USE AMENDMENT FILED
Monday, April 18, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 4, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, February 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 29, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 29, 2021NON-FINAL ACTION E-MAILED
Monday, March 29, 2021NON-FINAL ACTION WRITTEN
Monday, March 22, 2021ASSIGNED TO EXAMINER
Thursday, March 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 24, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

remagin surgery plastic oculofacial ophthalmology